KTTA
USDPasithea Therapeutics Corp. Common Stock
$0.690+0.010 (1.471%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.680
High
$0.710
Low
$0.650
Volume
0.08M
Company Fundamentals
Market Cap
5.1M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.13M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.65Current $0.690High $3.85
Related News
GlobeNewswire
Pasithea Therapeutics Announces Activation of Clinical Trial Site at University of Alabama at Birmingham for Ongoing Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ:KTTA) ("Pasithea" or the "Company"), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic oral MEK
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.